MY8500597A - Ergoline compounds, their preparation and pharmaceutical compositions containing them - Google Patents

Ergoline compounds, their preparation and pharmaceutical compositions containing them

Info

Publication number
MY8500597A
MY8500597A MY597/85A MY8500597A MY8500597A MY 8500597 A MY8500597 A MY 8500597A MY 597/85 A MY597/85 A MY 597/85A MY 8500597 A MY8500597 A MY 8500597A MY 8500597 A MY8500597 A MY 8500597A
Authority
MY
Malaysia
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
ergoline compounds
ergoline
Prior art date
Application number
MY597/85A
Other languages
English (en)
Inventor
Edmund Carl Kornfeld
Nicholas James Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY8500597A publication Critical patent/MY8500597A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
MY597/85A 1978-02-08 1985-12-30 Ergoline compounds, their preparation and pharmaceutical compositions containing them MY8500597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/875,978 US4166182A (en) 1978-02-08 1978-02-08 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Publications (1)

Publication Number Publication Date
MY8500597A true MY8500597A (en) 1985-12-31

Family

ID=25366703

Family Applications (1)

Application Number Title Priority Date Filing Date
MY597/85A MY8500597A (en) 1978-02-08 1985-12-30 Ergoline compounds, their preparation and pharmaceutical compositions containing them

Country Status (36)

Country Link
US (1) US4166182A (pt)
EP (1) EP0003667B1 (pt)
JP (1) JPS54115400A (pt)
AR (1) AR228341A1 (pt)
AT (1) AT371817B (pt)
AU (1) AU523172B2 (pt)
BE (1) BE873883A (pt)
BG (1) BG30474A3 (pt)
CA (1) CA1114368A (pt)
CH (1) CH639088A5 (pt)
CS (1) CS203951B2 (pt)
DD (1) DD141928A5 (pt)
DE (2) DE19375112I2 (pt)
DK (1) DK147362C (pt)
EG (1) EG14076A (pt)
ES (1) ES477547A1 (pt)
FI (1) FI65777C (pt)
FR (1) FR2416891A1 (pt)
GB (1) GB2014140B (pt)
GR (1) GR72776B (pt)
HU (1) HU179970B (pt)
IE (1) IE47827B1 (pt)
IL (1) IL56581A (pt)
LU (2) LU80886A1 (pt)
MX (2) MX5995E (pt)
MY (1) MY8500597A (pt)
NL (1) NL930106I2 (pt)
NZ (1) NZ189561A (pt)
PH (1) PH14903A (pt)
PL (3) PL126313B1 (pt)
PT (1) PT69172B (pt)
RO (3) RO81856A (pt)
SU (1) SU912045A3 (pt)
UA (1) UA6082A1 (pt)
YU (1) YU28279A (pt)
ZA (1) ZA79453B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
US4563461A (en) * 1983-03-10 1986-01-07 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4551529A (en) * 1983-10-06 1985-11-05 Warner-Lambert Company Guanine-N7 -oxide
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
EP0317269B1 (en) * 1987-11-20 1992-03-04 FARMITALIA CARLO ERBA S.r.l. Antiparkinson ergoline derivatives
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
DE3938701A1 (de) * 1989-11-20 1991-05-23 Schering Ag Neue agroclavin- und elymoclavin-derivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
DE69115221T2 (de) * 1990-09-28 1996-08-22 I F L O S A S Di Giorgio E Ald Methode zur Synthese eines Präparats zur Regulation der Empfängnis und des Menstruationszyklus mit onkostatischen antikinetosischen, preventiven und therapeutischen Eigenschaften zur Behandlung von Brustkrebs und Melanomen.
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
US5463060A (en) * 1992-05-21 1995-10-31 Eli Lilly And Company One-pot process
US6572879B1 (en) 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
IT1307934B1 (it) 1999-01-27 2001-11-29 Poli Ind Chimica Spa Processo per la preparazione di derivati alchimercaptometilergolinici.
WO2000054776A1 (en) * 1999-03-17 2000-09-21 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
US6388079B1 (en) 2000-08-29 2002-05-14 Scinopharm Singapore Pte Ltd. Process for preparing pergolide
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
CZ305160B6 (cs) * 2001-06-08 2015-05-27 Ipsen Pharma S.A.S. Chimérické somatostatin-dopaminové analogy
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
DE60324776D1 (de) * 2002-03-15 2009-01-02 Antibioticos Spa Verfahren zur synthese von pergolid
GB0409785D0 (en) 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
EP2113504A1 (en) * 2008-04-29 2009-11-04 LEK Pharmaceuticals D.D. Preparation of N-6 demethylated, 9,10-dihydrolysergic acid alkyl esters
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
CN104768565B (zh) 2012-11-01 2017-04-26 益普生制药股份有限公司 促生长素抑制素类似物及其二聚体
EP2930175A4 (en) 2012-12-10 2016-12-21 Kissei Pharmaceutical NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF
CN106866656A (zh) * 2017-02-28 2017-06-20 西南交通大学 一类麦角碱衍生物及其在预防和治疗精神疾病的用途
WO2019234069A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206772A1 (es) * 1972-07-21 1976-08-23 Lilly Co Eli Procedimiento para preparar una nueva d-2-halo-6-metil-8-ciano(carboxamido)metil ergolina
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3985752A (en) * 1974-12-06 1976-10-12 Eli Lilly And Company 6-Methyl-8-(substituted) methylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
JPS5283894A (en) * 1976-01-01 1977-07-13 Lilly Co Eli 88thiomethyl ergoline

Also Published As

Publication number Publication date
PL124704B1 (en) 1983-02-28
FI790351A (fi) 1979-08-09
CH639088A5 (fr) 1983-10-31
PT69172A (en) 1979-03-01
MX5995E (es) 1984-09-18
AR228341A1 (es) 1983-02-28
DD141928A5 (de) 1980-05-28
DK51379A (da) 1979-09-18
JPS6363544B2 (pt) 1988-12-07
HU179970B (en) 1983-01-28
AU4391779A (en) 1979-08-16
RO76889A (ro) 1981-08-30
ATA91479A (de) 1982-12-15
SU912045A3 (ru) 1982-03-07
FR2416891B1 (pt) 1981-10-16
BE873883A (fr) 1979-08-02
RO81856B (ro) 1983-05-30
LU88294I2 (fr) 1994-05-04
NL930106I2 (nl) 1997-02-03
RO81856A (ro) 1983-06-01
GB2014140A (en) 1979-08-22
US4166182A (en) 1979-08-28
NZ189561A (en) 1981-12-15
DK147362B (da) 1984-07-02
YU28279A (en) 1983-02-28
ES477547A1 (es) 1980-04-16
EP0003667A1 (en) 1979-08-22
JPS54115400A (en) 1979-09-07
GR72776B (pt) 1983-12-05
EP0003667B1 (en) 1982-07-14
DK147362C (da) 1988-06-27
CA1114368A (en) 1981-12-15
GB2014140B (en) 1982-08-04
AU523172B2 (en) 1982-07-15
PL120849B1 (en) 1982-03-31
IL56581A (en) 1982-05-31
IL56581A0 (en) 1979-05-31
PL213283A1 (pt) 1980-02-25
LU80886A1 (fr) 1979-06-07
EG14076A (en) 1983-12-31
RO81857A (ro) 1983-06-01
MX9203107A (es) 1992-07-31
DE2963320D1 (en) 1982-09-02
IE790232L (en) 1979-08-08
IE47827B1 (en) 1984-06-27
FI65777C (fi) 1984-07-10
PH14903A (en) 1982-01-29
RO81857B (ro) 1983-05-30
PL126313B1 (en) 1983-07-30
FR2416891A1 (fr) 1979-09-07
PT69172B (pt) 1992-05-29
BG30474A3 (en) 1981-06-15
ZA79453B (en) 1980-09-24
FI65777B (fi) 1984-03-30
DE19375112I2 (de) 2003-06-12
CS203951B2 (en) 1981-03-31
AT371817B (de) 1983-08-10
NL930106I1 (nl) 1993-10-18
UA6082A1 (uk) 1994-12-29

Similar Documents

Publication Publication Date Title
DE2963320D1 (en) Ergoline compounds, their preparation and pharmaceutical compositions containing them
IL56992A (en) N-heterocyclyl-4-piperidinamines,their preparation and pharmaceutical compositions containing them
IL57708A0 (en) Aminopropoxyindole derivatives,their preparation and pharmaceutical compositions containing them
IL55274A0 (en) Pinene derivatives, their preparation and pharmaceutical compositions containing them
DE2967274D1 (en) Beta-lactam-containing compounds, their preparation and pharmaceutical compositions containing them
IL61264A (en) Dihydro-piperazinylpyrazolobenzodiazepine compounds,their preparation and pharmaceutical compositions containing them
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
IL57297A0 (en) 4-amino-2-piperidinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL61614A0 (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
IL55254A (en) Bis-isoquinolinium compounds,their preparation and pharmaceutical compositions containing them
IL60094A0 (en) Tetracyclic compounds,their preparation and pharmaceutical compositions containing them
IL58620A (en) Aryltrifluoroethanol derivatives,their preparation and pharmaceutical compositions containing them
IL56816A0 (en) N-phenylaniline derivatives,their preparation and pharmaceutical compositions containing them
IL57891A (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
IL56686A0 (en) Acylaminoalkyl-syanoguanidines,their preparation and pharmaceutical compositions containing them
ZA793682B (en) New piperidylbenzimidazolinone derivatives,processes for their preparation and pharmaceutical compositions containing them
DE2966444D1 (en) Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them
IL56913A (en) Sprio-steroid-oxazolidinone derivatives,their preparation and pharmaceutical compositions containing them
IL56890A0 (en) 2-amino-carbazole derivatives,their preparation and pharmaceutical compositions containing them
DE2963868D1 (en) Carbostyrile derivatives, their preparation and pharmaceutical compositions containing them
IL56075A0 (en) Novel arylaminoimidazoline derivatives,their preparation and pharmaceutical compositions containing them
DE2960503D1 (en) Novel androstadienes, processes for their preparation and pharmaceutical compositions containing them
IL62519A0 (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
IL56349A0 (en) 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
HK12384A (en) Novel veratramides,their preparation and pharmaceutical compositions containing them